Skip to main content
Premium Trial:

Request an Annual Quote

Thomas Fairfield

Courtagen Life Sciences has appointed Thomas Fairfield to its board of directors. Fairfield has served as COO and a director of WMIH since May 2015, and prior to that was executive VP of Capmark Financial Group. He joined Capmark in March 2006 and has served in various roles at the firm, including COO, executive VP, general counsel, and secretary.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.